Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Validity of the PHQ-9 and PHQ-2 to screen for depression in nationwide primary care population in Latvia.

Rancans E, Trapencieris M, Ivanovs R, Vrublevska J.

Ann Gen Psychiatry. 2018 Aug 2;17:33. doi: 10.1186/s12991-018-0203-5. eCollection 2018.

2.

Association of Depression and Anxiety With the 10-Year Risk of Cardiovascular Mortality in a Primary Care Population of Latvia Using the SCORE System.

Ivanovs R, Kivite A, Ziedonis D, Mintale I, Vrublevska J, Rancans E.

Front Psychiatry. 2018 Jun 26;9:276. doi: 10.3389/fpsyt.2018.00276. eCollection 2018.

3.

Association of depression and anxiety with cardiovascular co-morbidity in a primary care population in Latvia: a cross-sectional study.

Ivanovs R, Kivite A, Ziedonis D, Mintale I, Vrublevska J, Rancans E.

BMC Public Health. 2018 Mar 6;18(1):328. doi: 10.1186/s12889-018-5238-7.

4.

Adaptation and validation of the Patient Health Questionnaire-9 to evaluate major depression in a primary care sample in Latvia.

Vrublevska J, Trapencieris M, Rancans E.

Nord J Psychiatry. 2018 Feb;72(2):112-118. doi: 10.1080/08039488.2017.1397191. Epub 2017 Nov 6.

PMID:
29105551
5.

Latvian family physicians' experience diagnosing depression in somatically presenting depression patients: A qualitative study.

Leff MS, Vrubļevska J, Lūse A, Rancāns E.

Eur J Gen Pract. 2017 Dec;23(1):91-97. doi: 10.1080/13814788.2017.1291626.

6.

Evidence-based national suicide prevention taskforce in Europe: A consensus position paper.

Zalsman G, Hawton K, Wasserman D, van Heeringen K, Arensman E, Sarchiapone M, Carli V, Höschl C, Winkler P, Balazs J, Purebl G, Kahn JP, Sáiz PA, Bobes J, Cozman D, Hegerl U, Rancāns E, Hadlaczky G, Van Audenhove C, Hermesh H, Sisask M, Peschayan AM, Kapusta N, Adomaitiene V, Steibliene V, Kosiewska I, Rozanov V, Courtet P, Zohar J; European Evidence-Based Suicide Prevention Program [EESPP] Group by the Expert Platform on Mental Health, Focus on Depression.

Eur Neuropsychopharmacol. 2017 Apr;27(4):418-421. doi: 10.1016/j.euroneuro.2017.01.012. Epub 2017 Feb 1. No abstract available.

PMID:
28161247
7.

The 12-month prevalence of depression and health care utilization in the general population of Latvia.

Vrublevska J, Trapencieris M, Snikere S, Grinberga D, Velika B, Pudule I, Rancans E.

J Affect Disord. 2017 Mar 1;210:204-210. doi: 10.1016/j.jad.2016.12.031. Epub 2016 Dec 28.

PMID:
28061411
8.

Relationship of suicide rates with climate and economic variables in Europe during 2000-2012.

Fountoulakis KN, Chatzikosta I, Pastiadis K, Zanis P, Kawohl W, Kerkhof AJ, Navickas A, Höschl C, Lecic-Tosevski D, Sorel E, Rancans E, Palova E, Juckel G, Isacsson G, Jagodic HK, Botezat-Antonescu I, Rybakowski J, Azorin JM, Cookson J, Waddington J, Pregelj P, Demyttenaere K, Hranov LG, Stevovic LI, Pezawas L, Adida M, Figuera ML, Jakovljević M, Vichi M, Perugi G, Andreassen OA, Vukovic O, Mavrogiorgou P, Varnik P, Dome P, Winkler P, Salokangas RK, From T, Danileviciute V, Gonda X, Rihmer Z, Forsman J, Grady A, Hyphantis T, Dieset I, Soendergaard S, Pompili M, Bech P.

Ann Gen Psychiatry. 2016 Aug 9;15:19. doi: 10.1186/s12991-016-0106-2. eCollection 2016.

9.

Prevalence and sociodemographic characteristics of self-reported suicidal behaviours in Latvia in 2010: A population-based study.

Rancāns E, Pulmanis T, Taube M, Spriņǵe L, Velika B, Pudule I, Grīnberga D.

Nord J Psychiatry. 2016;70(3):195-201. doi: 10.3109/08039488.2015.1077887. Epub 2015 Sep 11.

PMID:
26360335
10.

Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics.

Hargarter L, Cherubin P, Bergmans P, Keim S, Rancans E, Bez Y, Parellada E, Carpiniello B, Vidailhet P, Schreiner A.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Apr 3;58:1-7. doi: 10.1016/j.pnpbp.2014.11.006. Epub 2014 Nov 15.

11.

A prospective flexible-dose study of paliperidone palmitate in nonacute but symptomatic patients with schizophrenia previously unsuccessfully treated with oral antipsychotic agents.

Schreiner A, Bergmans P, Cherubin P, Keim S, Rancans E, Bez Y, Parellada E, Carpiniello B, Vidailhet P, Hargarter L.

Clin Ther. 2014 Oct 1;36(10):1372-88.e1. doi: 10.1016/j.clinthera.2014.08.014. Epub 2014 Oct 23. Erratum in: Clin Ther. 2014 Nov 1;36(11):1705.

12.

Relationship of suicide rates to economic variables in Europe: 2000-2011.

Fountoulakis KN, Kawohl W, Theodorakis PN, Kerkhof AJ, Navickas A, Höschl C, Lecic-Tosevski D, Sorel E, Rancans E, Palova E, Juckel G, Isacsson G, Jagodic HK, Botezat-Antonescu I, Warnke I, Rybakowski J, Azorin JM, Cookson J, Waddington J, Pregelj P, Demyttenaere K, Hranov LG, Stevovic LI, Pezawas L, Adida M, Figuera ML, Pompili M, Jakovljević M, Vichi M, Perugi G, Andreassen O, Vukovic O, Mavrogiorgou P, Varnik P, Bech P, Dome P, Winkler P, Salokangas RK, From T, Danileviciute V, Gonda X, Rihmer Z, Benhalima JF, Grady A, Leadholm AK, Soendergaard S, Nordt C, Lopez-Ibor J.

Br J Psychiatry. 2014 Dec;205(6):486-96. doi: 10.1192/bjp.bp.114.147454. Epub 2014 Oct 30. Erratum in: Br J Psychiatry. 2015 Feb;206(2):169. Andrasen, Ole [corrected to Andreassen, Ole].

PMID:
25359926
13.

World Federation of Societies of Biological Psychiatry guidelines for the pharmacological treatment of dementias in primary care.

Ihl R, Bunevicius R, Frölich L, Winblad B, Schneider LS, Dubois B, Burns A, Thibaut F, Kasper S, Möller HJ; WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Dementia.

Int J Psychiatry Clin Pract. 2015 Mar;19(1):2-7. doi: 10.3109/13651501.2014.961931. Epub 2014 Oct 18. Review.

PMID:
25195764
14.

Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant.

Vieta E, Thase ME, Naber D, D'Souza B, Rancans E, Lepola U, Olausson B, Szamosi J, Wilson E, Hosford D, Dunbar G, Tummala R, Eriksson H.

Eur Neuropsychopharmacol. 2014 Apr;24(4):564-74. doi: 10.1016/j.euroneuro.2013.12.008. Epub 2013 Dec 21.

PMID:
24507016
15.

A prospective follow-up study of first-episode acute transient psychotic disorder in Latvia.

Rusaka M, Rancāns E.

Ann Gen Psychiatry. 2014 Feb 6;13(1):4. doi: 10.1186/1744-859X-13-4.

16.

Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychotics.

Schreiner A, Lahaye M, Peuskens J, Naber D, Dilbaz N, Millet B, Franco MA, Rancans E, Turczynski J, Smeraldi E, Lara E, Neznanov NG.

Expert Opin Pharmacother. 2014 Apr;15(5):593-603. doi: 10.1517/14656566.2014.884071. Epub 2014 Feb 3.

PMID:
24491033
17.

The point prevalence of depression and associated sociodemographic correlates in the general population of Latvia.

Rancans E, Vrublevska J, Snikere S, Koroleva I, Trapencieris M.

J Affect Disord. 2014 Mar;156:104-10. doi: 10.1016/j.jad.2013.11.022. Epub 2013 Dec 7.

PMID:
24388684
18.

First-episode acute and transient psychotic disorder in Latvia: a 6-year follow-up study.

Rusaka M, Rancāns E.

Nord J Psychiatry. 2014 Jan;68(1):24-9. doi: 10.3109/08039488.2012.761726. Epub 2013 Feb 5.

PMID:
23383651
19.
20.

Psychiatry in Latvia: a journey through the past three centuries.

Rancāns E, Tērauds E, Taube M.

Nord J Psychiatry. 2012 Dec;66(6):428-32. doi: 10.3109/08039488.2012.669793. Epub 2012 Mar 20.

PMID:
22429129

Supplemental Content

Loading ...
Support Center